Scarica l'app Stockscreener
47.67
1.49%
0.625
Precedente Chiudi:
$47.05
Aprire:
$46.8
Volume 24 ore:
860.32K
Relative Volume:
0.37
Capitalizzazione di mercato:
$6.14B
Reddito:
$10.12M
Utile/perdita netta:
$-280.49M
Rapporto P/E:
-16.50
EPS:
-2.89
Flusso di cassa netto:
$-188.51M
1 W Prestazione:
+7.69%
1M Prestazione:
+31.65%
6M Prestazione:
+64.20%
1 anno Prestazione:
+9.22%
Intervallo 1D:
$46.58
$47.99
Intervallo di 1 settimana:
$43.28
$47.87
Portata 52W:
$21.51
$56.00
Avidity Biosciences Inc Stock (RNA) Company Profile
Nome
Avidity Biosciences Inc
Settore
Industria
Telefono
858-401-7900
Indirizzo
10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Confronta RNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNA
Avidity Biosciences Inc
|
47.69 | 5.82B | 10.12M | -280.49M | -188.51M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.43 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.97 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.62 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.79 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Avidity Biosciences Inc Stock (RNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-06-24 | Iniziato | Bernstein | Outperform |
| 2025-06-17 | Iniziato | Wolfe Research | Outperform |
| 2025-06-11 | Iniziato | Raymond James | Strong Buy |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-12-20 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-09-24 | Iniziato | Goldman | Buy |
| 2024-08-28 | Iniziato | Barclays | Overweight |
| 2024-05-03 | Iniziato | BofA Securities | Buy |
| 2024-03-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-05-22 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-07-20 | Iniziato | Chardan Capital Markets | Buy |
| 2022-07-12 | Iniziato | Raymond James | Strong Buy |
| 2021-09-07 | Iniziato | Evercore ISI | Outperform |
| 2021-06-17 | Iniziato | Needham | Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-07-07 | Iniziato | Cowen | Outperform |
| 2020-07-07 | Iniziato | Credit Suisse | Outperform |
| 2020-07-07 | Iniziato | SVB Leerink | Outperform |
| 2020-07-07 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Avidity Biosciences Inc Borsa (RNA) Ultime notizie
Analyzing recovery setups for Avidity Biosciences Inc. investorsLong Setup & Community Trade Idea Sharing - Newser
Avidity Biosciences Inc. stock trend forecastTrade Exit Summary & Technical Confirmation Trade Alerts - Newser
What moving averages say about Avidity Biosciences Inc.Market Growth Summary & Real-Time Volume Trigger Notifications - Newser
How to monitor Avidity Biosciences Inc. with trend dashboardsPortfolio Return Report & Free Technical Confirmation Trade Alerts - Newser
RNA Therapeutics Leader Avidity Biosciences to Share AOC Platform Updates at Major Healthcare Conferences - Stock Titan
Does Avidity Biosciences Inc. show high probability of rebound2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Detecting price anomalies in Avidity Biosciences Inc. with AIJuly 2025 Decliners & Stepwise Swing Trade Plans - Newser
Technical analysis overview for Avidity Biosciences Inc. stockQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Is Avidity Biosciences Inc. stock entering bullish territoryQuarterly Earnings Summary & Real-Time Volume Surge Alerts - Newser
Technical Heatmap Flags Avidity Biosciences Inc. for Watch getLinesFromResByArray error: size == 0 - 더경남뉴스
Real time pattern detection on Avidity Biosciences Inc. stockWeekly Profit Report & Community Trade Idea Sharing - Newser
RNA Stock Moves More Than 30% in a Week: What's Driving This Rally? - MSN
How to integrate Avidity Biosciences Inc. into portfolio analysis tools2025 Market Outlook & Weekly High Conviction Ideas - Newser
Will breakout in Avidity Biosciences Inc. lead to full recovery2025 Top Decliners & Daily Entry Point Alerts - Newser
Can momentum traders help lift Avidity Biosciences Inc.2025 Big Picture & High Win Rate Trade Alerts - Newser
Avidity Biosciences Inc. stock momentum explainedJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
Reversal indicators forming on Avidity Biosciences Inc. stockTrade Volume Report & Fast Momentum Stock Entry Tips - Newser
Market reaction to Avidity Biosciences Inc.’s recent newsWeekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
What high frequency data says about Avidity Biosciences Inc.2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - Newser
Avidity Biosciences' RNA Stock Surges 36% Amid Novartis Acquisition Rumors - AInvest
Avidity Biosciences Announces Positive Topline Phase 1/2 FORTITUDE™ Data Demonstrating Consistent Improvement Across Multiple Functional Measures Compared to Placebo in Del-Brax Treated FSHD Participants - Quantisnow
What technical models suggest about Avidity Biosciences Inc.’s comeback2025 Performance Recap & Advanced Swing Trade Entry Plans - Newser
Will earnings trigger a reversal in Avidity Biosciences Inc.Portfolio Growth Summary & Technical Buy Zone Confirmation - Newser
Applying sector rotation models to Avidity Biosciences Inc.July 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Is Avidity Biosciences Inc. a top pick in the sectorPortfolio Value Summary & Verified Short-Term Plans - theviewers.co.kr
Can swing trading help recover from Avidity Biosciences Inc. lossesPortfolio Value Summary & Weekly Watchlist of Top Performers - Newser
Novartis Reportedly Eyeing To Acquire Avidity Biosciences: But Retail Expects Management To Sell Only At Significant Premium - MSN
Can Avidity Biosciences Inc. recover in the next quarterShort Setup & Verified Swing Trading Watchlists - Newser
Avidity Biosciences CMO Hughes Buys, Sells Shares at $10.16 and $46.4 - AInvest
Risk vs reward if holding onto Avidity Biosciences Inc.Analyst Downgrade & Weekly High Return Stock Forecasts - Newser
Avidity Bio Climbs on Report of Novartis Takeover - MSN
Is a relief rally coming for Avidity Biosciences Inc. holdersM&A Rumor & Safe Entry Trade Reports - Newser
Avidity Biosciences Inc. Charts Flash Early Recovery SignalsEarnings Overview Summary & Fast Gain Swing Trade Alerts - newsimpact.co.kr
Avidity Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowMarket Trend Report & Weekly Top Stock Performers List - Newser
Myotonic Dystrophy Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Dyne Therapeutics, Avidity Biosciences, Harmony Biosciences, AMO Pharma, Lupin - Barchart.com
Momentum Indicator Shows Bearish Divergence in Avidity Biosciences Inc.July 2025 Technicals & Low Drawdown Momentum Trade Ideas - metal.it
Avidity Biosciences Q2 Earnings: Strong Progress and Financial Position - AInvest
Trend analysis for Avidity Biosciences Inc. this weekJuly 2025 Update & Fast Gain Stock Trading Tips - Newser
Price Floor Holding on Avidity Biosciences Inc. — Rebound PossibleWeekly Stock Analysis & Weekly Sector Rotation Insights - metal.it
What makes Avidity Biosciences Inc. stock price move sharplyJuly 2025 Weekly Recap & Accurate Entry/Exit Alerts - thegnnews.com
Avidity Biosciences Advances RNA Therapeutics with Strong Q2 - TipRanks
What indicators show strength in Avidity Biosciences Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Avidity Biosciences (RNA) CHRO McCarthy sells $465k in stock By Investing.com - Investing.com South Africa
Avidity Biosciences (RNA) CHRO McCarthy sells $465k in stock - Investing.com
Avidity Biosciences Executives Sell Shares Under Trading Plans - TradingView
Avidity Biosciences Executives Make Substantial Share Trades Amid Company News - AInvest
Avidity Biosciences Inc Azioni (RNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avidity Biosciences Inc Azioni (RNA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hughes Steven George | Chief Medical Officer |
Aug 22 '25 |
Sale |
46.40 |
2,208 |
102,462 |
38,867 |
| McCarthy Teresa | Chief Human Resources Officer |
Aug 15 '25 |
Option Exercise |
22.34 |
10,000 |
223,400 |
107,130 |
| McCarthy Teresa | Chief Human Resources Officer |
Aug 15 '25 |
Sale |
46.56 |
10,000 |
465,632 |
97,130 |
0.96%
7.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):